NR4A1-induced increase in the sensitivity of a human gastric cancer line to TNFα-mediated apoptosis is associated with the inhibition of JNK/Parkin-dependent mitophagy Retraction in /10.3892/ijo.2024.5666

Yan,Hongzhu; Xiao,Feng; Zou,Jue; Qiu,Chengmin; Sun,Weiwei; Gu,Minmin; Zhang,Li

doi:10.3892/ijo.2017.4216

NR4A1-induced increase in the sensitivity of a human gastric cancer line to TNFα-mediated apoptosis is associated with the inhibition of JNK/Parkin-dependent mitophagy

Retraction in: /10.3892/ijo.2024.5666

Authors:
- Hongzhu Yan
- Feng Xiao
- Jue Zou
- Chengmin Qiu
- Weiwei Sun
- Minmin Gu
- Li Zhang
View Affiliations

Affiliations: Department of Pathology, Seventh People's Hospital of Shanghai University of TCM, Shanghai 200137, P.R. China, Department of Pathology, Songjiang Hospital Affiliated to Τhe First People's Hospital, Shanghai Jiao Tong University, Shanghai 201600, P.R. China
Published online on: December 4, 2017 https://doi.org/10.3892/ijo.2017.4216
Pages: 367-378
Copyright: © Yan et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Tumor necrosis factor α (TNFα)-based immunotherapy is the vital host defense system against the progression of gastric cancer (GC) as a pro-inflammatory and pro-apoptotic cytokine. However, resistance limits its therapeutic efficiency. Therefore, an increasing number of studies are focusing on the development of drugs or methods with which to enhance the treatment efficacy of TNFα. Nuclear receptor subfamily 4 group A member 1 (NR4A1) has been shown to exert antitumor effects through several mechanisms, such as by inhibiting proliferation, as well as pro-apoptotic and potent pro-oxidant effects. In this study, we examined the effects and mechanisms of action of NR4A1 on the apoptosis of GC cells treated with TNFα, with particular focus on mitochondrial homeostasis. We found that TNFα treatment decreased NR4A1 expression. Moreover, the overexpression of NR4A1 in the presence of TNFα further increased GC cell apoptosis. Mechanistically, the overexpression of NR4A1 augmented caspase-9-dependent mitochondrial apoptosis, as evidenced by reduced mitochondrial membrane potential, reactive oxygen species (ROS) overproduction, mitochondrial permeability transition pore (mPTP) opening and the leakage of cytochrome c (Cyt-c) leakage. Moreover, NR4A1 overexpression also evoked mitochondrial energy disorder via the suppression of mitochondrial respiratory complex expression. Furthermore, we found that TNFα treatment activated Parkin-dependent mitophagy. Excessive Parkin-dependent mitophagy blocked mitochondrial apoptosis, undermining the toxic effects of TNFα on cells. However, NR4A1 overexpression suppressed Parkin-dependent mitophagy via the inhibition of c-Jun N-terminal kinase (JNK). Re-activation of the JNK/Parkin pathway abrogated the inhibitory effects of NR4A1 on mitophagy, eventually limiting cell apoptosis. Collectively, this study confirmed that NR4A1 sensitizes GC cells to TNFα-induced apoptosis through the inhibition of JNK/Parkin-dependent mitophagy.

View Figures

View References

1	Balakrishnan M, George R, Sharma A and Graham DY: Changing trends in stomach cancer throughout the world. Curr Gastroenterol Rep. 19:362017. View Article : Google Scholar : PubMed/NCBI
2	Suzuki H and Mori H: World trends for H. pylori eradication therapy and gastric cancer prevention strategy by H. pylori test-and-treat. J Gastroenterol. Nov 14–2017.Epub ahead of print. View Article : Google Scholar : PubMed/NCBI
3	Lee HS, Kim WH, Kwak Y, Koh J, Bae JM, Kim KM, Chang MS, Han HS, Kim JM, Kim HW, et al Gastrointestinal Pathology Study Group of Korean Society of Pathologists; Molecular Pathology Study Group of Korean Society of Pathologists: Molecular testing for gastrointestinal cancer. J Pathol Transl Med. 51:103–121. 2017. View Article : Google Scholar : PubMed/NCBI
4	Paoletti X, Oba K, Burzykowski T, Michiels S, Ohashi Y, Pignon JP, Rougier P, Sakamoto J, Sargent D, Sasako M, et al GASTRIC (Global Advanced/Adjuvant Stomach Tumor Research International Collaboration) Group: Benefit of adjuvant chemotherapy for resectable gastric cancer: A meta-analysis. JAMA. 303:1729–1737. 2010. View Article : Google Scholar : PubMed/NCBI
5	Procaccio L, Schirripa M, Fassan M, Vecchione L, Bergamo F, Prete AA, Intini R, Manai C, Dadduzio V, Boscolo A, et al: Immunotherapy in gastrointestinal cancers. BioMed Res Int. 2017:43465762017. View Article : Google Scholar : PubMed/NCBI
6	Bie Q, Jin C, Zhang B and Dong H: IL-17B: A new area of study in the IL-17 family. Mol Immunol. 90:50–56. 2017. View Article : Google Scholar : PubMed/NCBI
7	Du LC and Gao R: Role of TNFα -308G/A gene polymorphism in gastric cancer risk: A case control study and meta-analysis. Turk J Gastroenterol. 28:272–282. 2017. View Article : Google Scholar : PubMed/NCBI
8	Hong JT, Son DJ, Lee CK, Yoon DY, Lee DH and Park MH: Interleukin 32, inflammation and cancer. Pharmacol Ther. 174:127–137. 2017. View Article : Google Scholar : PubMed/NCBI
9	Abozeid M, Rosato A and Sommaggio R: Immunotherapeutic strategies for gastric carcinoma: A review of preclinical and clinical recent development. BioMed Res Int. 2017:57912622017. View Article : Google Scholar : PubMed/NCBI
10	Grierson P, Lim KH and Amin M: Immunotherapy in gastrointestinal cancers. J Gastrointest Oncol. 8:474–484. 2017. View Article : Google Scholar : PubMed/NCBI
11	Procaccio L, Schirripa M, Fassan M, Vecchione L, Bergamo F, Prete AA, Intini R, Manai C, Dadduzio V, Boscolo A, et al: Immunotherapy in gastrointestinal cancers. BioMed Res Int. 2017:43465762017. View Article : Google Scholar : PubMed/NCBI
12	Tsujimoto H, Ono S, Ichikura T, Matsumoto Y, Yamamoto J and Hase K: Roles of inflammatory cytokines in the progression of gastric cancer: Friends or foes? Gastric Cancer. 13:212–221. 2010. View Article : Google Scholar : PubMed/NCBI
13	Carrasco-Pozo C, Tan KN, Reyes-Farias M, De La Jara N, Ngo ST, Garcia-Diaz DF, Llanos P, Cires MJ and Borges K: The deleterious effect of cholesterol and protection by quercetin on mitochondrial bioenergetics of pancreatic β-cells, glycemic control and inflammation: In vitro and in vivo studies. Redox Biol. 9:229–243. 2016. View Article : Google Scholar : PubMed/NCBI
14	Kakimoto PA and Kowaltowski AJ: Effects of high fat diets on rodent liver bioenergetics and oxidative imbalance. Redox Biol. 8:216–225. 2016. View Article : Google Scholar : PubMed/NCBI
15	Kheradpezhouh E, Barritt GJ and Rychkov GY: Curcumin inhibits activation of TRPM2 channels in rat hepatocytes. Redox Biol. 7:1–7. 2016. View Article : Google Scholar :
16	Kleszczyński K, Zillikens D and Fischer TW: Melatonin enhances mitochondrial ATP synthesis, reduces reactive oxygen species formation, and mediates translocation of the nuclear erythroid 2-related factor 2 resulting in activation of phase-2 antioxidant enzymes (γ-GCS, HO-1, NQO1) in ultraviolet radiation-treated normal human epidermal keratinocytes (NHEK). J Pineal Res. 61:187–197. 2016. View Article : Google Scholar
17	Ni HM, Williams JA and Ding WX: Mitochondrial dynamics and mitochondrial quality control. Redox Biol. 4:6–13. 2015. View Article : Google Scholar :
18	Xu S, Pi H, Zhang L, Zhang N, Li Y, Zhang H, Tang J, Li H, Feng M, Deng P, et al: Melatonin prevents abnormal mitochondrial dynamics resulting from the neurotoxicity of cadmium by blocking calcium-dependent translocation of Drp1 to the mitochondria. J Pineal Res. 60:291–302. 2016. View Article : Google Scholar : PubMed/NCBI
19	Quijano C, Trujillo M, Castro L and Trostchansky A: Interplay between oxidant species and energy metabolism. Redox Biol. 8:28–42. 2016. View Article : Google Scholar : PubMed/NCBI
20	Du K, Ramachandran A and Jaeschke H: Oxidative stress during acetaminophen hepatotoxicity: Sources, pathophysiological role and therapeutic potential. Redox Biol. 10:148–156. 2016. View Article : Google Scholar : PubMed/NCBI
21	Pawlak A, Strzadala L and Kalas W: Non-genomic effects of the NR4A1/Nur77/TR3/NGFIB orphan nuclear receptor. Steroids. 95:1–6. 2015. View Article : Google Scholar : PubMed/NCBI
22	Wenzl K, Troppan K, Neumeister P and Deutsch AJ: The nuclear orphan receptor NR4A1 and NR4A3 as tumor suppressors in hematologic neoplasms. Curr Drug Targets. 16:38–46. 2015. View Article : Google Scholar
23	Wu H, Bi J, Peng Y, Huo L, Yu X, Yang Z, Zhou Y, Qin L, Xu Y, Liao L, et al: Nuclear receptor NR4A1 is a tumor suppressor down-regulated in triple-negative breast cancer. Oncotarget. 8:54364–54377. 2017.PubMed/NCBI
24	Beard JA, Tenga A and Chen T: The interplay of NR4A receptors and the oncogene-tumor suppressor networks in cancer. Cell Signal. 27:257–266. 2015. View Article : Google Scholar
25	Alonso-González C, González A, Martínez-Campa C, Gómez-Arozamena J and Cos S: Melatonin sensitizes human breast cancer cells to ionizing radiation by downregulating proteins involved in double-strand DNA break repair. J Pineal Res. 58:189–197. 2015. View Article : Google Scholar : PubMed/NCBI
26	Zhu H, Jin Q, Li Y, Ma Q, Wang J, Li D, Zhou H and Chen Y: Melatonin protected cardiac microvascular endothelial cells against oxidative stress injury via suppression of IP3R-[Ca(2+)] c/VDAC-[Ca(2+)]m axis by activation of MAPK/ERK signaling pathway. Cell Stress Chaperones. Jul 1–2017.Epub ahead of print. View Article : Google Scholar
27	Lin C, Chao H, Li Z, Xu X, Liu Y, Hou L, Liu N and Ji J: Melatonin attenuates traumatic brain injury-induced inflammation: A possible role for mitophagy. J Pineal Res. 61:177–186. 2016. View Article : Google Scholar : PubMed/NCBI
28	Lin YW, Lee LM, Lee WJ, Chu CY, Tan P, Yang YC, Chen WY, Yang SF, Hsiao M and Chien MH: Melatonin inhibits MMP-9 transactivation and renal cell carcinoma metastasis by suppressing Akt-MAPKs pathway and NF-κB DNA-binding activity. J Pineal Res. 60:277–290. 2016. View Article : Google Scholar : PubMed/NCBI
29	Zhang Y, Zhou H, Wu W, Shi C, Hu S, Yin T, Ma Q, Han T, Zhang Y, Tian F, et al: Liraglutide protects cardiac microvascular endothelial cells against hypoxia/reoxygenation injury through the suppression of the SR-Ca(2+)-XO-ROS axis via activation of the GLP-1R/PI3K/Akt/survivin pathways. Free Radic Biol Med. 95:278–292. 2016. View Article : Google Scholar : PubMed/NCBI
30	de Luxán-Delgado B, Potes Y, Rubio-González A, Caballero B, Solano JJ, Fernández-Fernández M, Bermúdez M, Rodrigues Moreira, Guimarães M, Vega-Naredo I, Boga JA, et al: Melatonin reduces endoplasmic reticulum stress and autophagy in liver of leptin-deficient mice. J Pineal Res. 61:108–123. 2016. View Article : Google Scholar : PubMed/NCBI
31	King AL, Mantena SK, Andringa KK, Millender-Swain T, Dunham-Snary KJ, Oliva CR, Griguer CE and Bailey SM: The methyl donor S-adenosylmethionine prevents liver hypoxia and dysregulation of mitochondrial bioenergetic function in a rat model of alcohol-induced fatty liver disease. Redox Biol. 9:188–197. 2016. View Article : Google Scholar : PubMed/NCBI
32	Mailloux RJ, Craig Ayre D and Christian SL: Induction of mitochondrial reactive oxygen species production by GSH mediated S-glutathionylation of 2-oxoglutarate dehydrogenase. Redox Biol. 8:285–297. 2016. View Article : Google Scholar : PubMed/NCBI
33	Kang JW, Hong JM and Lee SM: Melatonin enhances mitophagy and mitochondrial biogenesis in rats with carbon tetrachloride-induced liver fibrosis. J Pineal Res. 60:383–393. 2016. View Article : Google Scholar : PubMed/NCBI
34	Li QX, Ke N, Sundaram R and Wong-Staal F: NR4A1, 2, 3 - an orphan nuclear hormone receptor family involved in cell apoptosis and carcinogenesis. Histol Histopathol. 21:533–540. 2006.PubMed/NCBI
35	Dan Dunn J, Alvarez LA, Zhang X and Soldati T: Reactive oxygen species and mitochondria: A nexus of cellular homeostasis. Redox Biol. 6:472–485. 2015. View Article : Google Scholar : PubMed/NCBI
36	Zhang J: Teaching the basics of autophagy and mitophagy to redox biologists–mechanisms and experimental approaches. Redox Biol. 4:242–259. 2015. View Article : Google Scholar
37	Mukherjee D, Ghosh AK, Dutta M, Mitra E, Mallick S, Saha B, Reiter RJ and Bandyopadhyay D: Mechanisms of isoproterenol-induced cardiac mitochondrial damage: Protective actions of melatonin. J Pineal Res. 58:275–290. 2015. View Article : Google Scholar : PubMed/NCBI
38	Xin Z, Jiang S, Jiang P, Yan X, Fan C, Di S, Wu G, Yang Y, Reiter RJ and Ji G: Melatonin as a treatment for gastrointestinal cancer: A review. J Pineal Res. 58:375–387. 2015. View Article : Google Scholar : PubMed/NCBI
39	Nacarelli T, Azar A and Sell C: Mitochondrial stress induces cellular senescence in an mTORC1-dependent manner. Free Radic Biol Med. 95:133–154. 2016. View Article : Google Scholar : PubMed/NCBI
40	Bernardini JP, Lazarou M and Dewson G: Parkin and mitophagy in cancer. Oncogene. 36:1315–1327. 2017. View Article : Google Scholar
41	Jankowski M: The role of JNK pathway in familial Parkinson's disease. Postepy Biochem. 53:297–303. 2007.In Polish.
42	Lordick F and Janjigian YY: Clinical impact of tumour biology in the management of gastroesophageal cancer. Nat Rev Clin Oncol. 13:348–360. 2016. View Article : Google Scholar : PubMed/NCBI
43	Ishimoto T, Baba H, Izumi D, Sugihara H, Kurashige J, Iwatsuki M and Tan P: Current perspectives toward the identification of key players in gastric cancer microRNA dysregulation. Int J Cancer. 138:1337–1349. 2016. View Article : Google Scholar
44	Scartozzi M, Bittoni A, Pistelli M, Galizia E, Berardi R, Giampieri R, Faloppi L and Cascinu S: Toward molecularly selected chemotherapy for advanced gastric cancer: State of the art and future perspectives. Cancer Treat Rev. 35:451–462. 2009. View Article : Google Scholar : PubMed/NCBI
45	Myint ZW and Goel G: Role of modern immunotherapy in gastrointestinal malignancies: A review of current clinical progress. J Hematol Oncol. 10:862017. View Article : Google Scholar : PubMed/NCBI
46	Gao L, Zhao YC, Liang Y, Lin XH, Tan YJ, Wu DD, Li XZ, Ye BZ, Kong FQ, Sheng JZ, et al: The impaired myocardial ischemic tolerance in adult offspring of diabetic pregnancy is restored by maternal melatonin treatment. J Pineal Res. 61:340–352. 2016. View Article : Google Scholar : PubMed/NCBI
47	Rizzo NR, Hank NC and Zhang J: Detecting presence of cardiovascular disease through mitochondria respiration as depicted through biophotonic emission. Redox Biol. 8:11–17. 2016. View Article : Google Scholar : PubMed/NCBI
48	Doskey CM, Buranasudja V, Wagner BA, Wilkes JG, Du J, Cullen JJ and Buettner GR: Tumor cells have decreased ability to metabolize H₂O₂: Implications for pharmacological ascorbate in cancer therapy. Redox Biol. 10:274–284. 2016. View Article : Google Scholar : PubMed/NCBI
49	Eirin A, Ebrahimi B, Kwon SH, Fiala JA, Williams BJ, Woollard JR, He Q, Gupta RC, Sabbah HN, Prakash YS, et al: Restoration of mitochondrial cardiolipin attenuates cardiac damage in swine renovascular hypertension. J Am Heart Assoc. 5:e0031182016. View Article : Google Scholar : PubMed/NCBI
50	Zhang W, Ren H, Xu C, Zhu C, Wu H, Liu D, Wang J, Liu L, Li W, Ma Q, et al: Hypoxic mitophagy regulates mitochondrial quality and platelet activation and determines severity of I/R heart injury. eLife. 5:e214072016. View Article : Google Scholar : PubMed/NCBI
51	Zhang W, Siraj S, Zhang R and Chen Q: Mitophagy receptor FUNDC1 regulates mitochondrial homeostasis and protects the heart from I/R injury. Autophagy. 13:1080–1081. 2017. View Article : Google Scholar : PubMed/NCBI
52	Mouton-Liger F, Jacoupy M, Corvol JC and Corti O: PINK1/Parkin-dependent mitochondrial surveillance: From pleiotropy to Parkinson's disease. Front Mol Neurosci. 10:1202017. View Article : Google Scholar : PubMed/NCBI
53	Chourasia AH and Macleod KF: Tumor suppressor functions of BNIP3 and mitophagy. Autophagy. 11:1937–1938. 2015. View Article : Google Scholar : PubMed/NCBI